WuXi AppTec

Colin Smith, M.S. has left WuXi AppTec as a Senior Validation Engineer (Sterilization) in the United States to join Bracco Medical Technologies as a Sr. Design Assurance Engineer...

WuXi AppTec is involved in the research and development of a prodrug for hepatitis B virus capsid assembly modulation...

WuXi AppTec opened its first high potency oral drug product manufacturing facility in 2022, expanding its integrated drug product R&D and manufacturing services...

WuXi AppTec is a global company headquartered in Shanghai, providing a comprehensive range of R&D and manufacturing services to the...

WuXi AppTec will hold its Q3 2024 earnings call on November 18 with participation from Co-CEOs Dr. Minzhang Chen and Dr. Qing Yang, CFO Ms. Ming Shi, and other executives...